What are the lessons from the GQHC v Commissioner of Taxation case?

If you’re claiming the R&D Tax Incentive, the GQHC v Commissioner of Taxation case should be on your radar. It’s a wake-up call for any business relying on AusIndustry’s past silence as a green light.

The case shows the ATO can claw back your R&D claim—challenging not just your costs, but the eligibility of the entire activity—even if AusIndustry has previously reviewed your registration without issue.

Why it matters?

The R&D Tax Incentive is governed by two agencies:

  • AusIndustry (now DISR) decides if your activities are eligible.
  • The ATO reviews your expenses.

But if AusIndustry hasn’t issued a formal Finding, the ATO can step in and dispute the eligibility of your activities. That’s exactly what happened to GQHC.

What do you need to do?

  • Strengthen your documentation – You need more than a technical hunch. You need formal hypotheses, controls, clear outcomes, and detailed records.
  • Be cautious with consumables – If your input turns into your output (think feed into chickens or chemicals into final products), the ATO might treat it as feedstock—and strip it out of your claim.
  • Don’t rely on “no further action” – AusIndustry giving you a pass doesn’t protect you from the ATO’s microscope.
  • Get expert advice before it gets messy – You don’t want to be arguing over microbiota digestion in front of a tribunal.

Read the full breakdown of the R&D Tax Incentive here

Worried about the ATO rejecting your R&D activities?
Speak with an expert now.ATO compliance R&D tax incentive

Background – What actually happened?

GQHC, a poultry company, had claimed the R&D incentive for work on feed trials, incubation systems, water treatments, and portable equipment. AusIndustry had reviewed multiple years without objection, and even the ATO had previously ticked off a claim.

But in 2023, the ATO challenged everything—not just the costs, but whether the activities were R&D at all under s.355-25. They also argued that chicken feed was feedstock input expenditure under s.355-465.

The Tribunal agreed.

Feedstock redefined

The AAT ruled that chicken feed was “digestively transformed” into chickens, even though the chickens weren’t sold. That meant the feed costs had to be stripped out of the claim.

This interpretation goes further than earlier cases, such as GHP v Commissioner of Taxation, and even appears to contradict the ATO’s own Taxation Ruling TR 2013/3—which says materials used but not transformed shouldn’t be feedstock.

The ATO vs. Ausindustry

One of the most concerning aspects was the Tribunal siding with the ATO on activity eligibility—because AusIndustry hadn’t issued a formal Finding under section 27F of the IR&D Act 1986.

The takeaway? No Finding, no protection.

AusIndustry’s past reviews meant nothing because they hadn’t been formalised. This gives the ATO more room to challenge claims, especially for complex or high-value projects.

Unsure if your documentation meets tribunal expectations?
Book a chat with an expert now.

ATO compliance R&D tax incentive

What can we take away from this?

The AAT’s ruling in GQHC set a worrying precedent—especially for anyone in agriculture, food production, pharmaceuticals, biotech, and manufacturing.

Here’s the big picture:

  • The ATO now has precedent to question your activities unless AusIndustry has made a formal decision (which rarely happens).
  • Feedstock is being interpreted widely—if the input even vaguely ends up in the product, the ATO may disallow the cost.
  • Scientific method matters—If you’re not setting hypotheses, documenting variables, and using controls, your claim is at risk.
  • Past approvals offer no protection—Even a decade of compliance doesn’t guarantee your claim is safe.

This decision also risks impacting sectors like:

  • Clinical trials – where drug inputs may be deemed transformed into patient outcomes.
  • Biotech and pharma – where culture media or genetic materials end up in a final therapeutic.
  • AgTech – where inputs like seed, fertiliser or feed may be considered transformed into outputs.

A word on TR 2013/3

Taxation Ruling TR 2013/3 was meant to clarify what counts as feedstock. It said that materials used to process or transform (but not themselves transformed) were not feedstock inputs.

That’s been widely relied on.

But in GQHC, the Tribunal just… ignored it. They didn’t apply it. They didn’t explain why. That creates real uncertainty—because the ATO could now ignore their own guidance and argue for broader interpretations.

❝It’s not just a bad result—it’s a signal that the rules you thought you knew may not protect you anymore.❞

Who’s most at risk?

This decision could hit hardest in:

  • Agriculture & AgTech – feed, fertilisers, seed inputs
  • Biotech & Pharma – culture media, genetic materials
  • Clinical trials – drug inputs possibly seen as “transformed”
  • Manufacturing – where inputs are consumed in output

Need help with the R&D Tax Incentive?

We write R&D claims that stand up under scrutiny—and we’ve been through both ATO and AusIndustry audits. We know how to prepare documentation that matches legislation, case law, and tribunal expectations.

❝ Bulletpoint is Australia’s highest-rated R&D tax consultancy—with over 280 five-star Google reviews. We’ve helped clients through audits, objections and reviews—and we write claims that hold up.❞

The GQHC ruling sets a worrying precedent. It widens the ATO’s authority and stretches the feedstock definition. And it shows that even a decade of past compliance won’t protect you if your current documentation falls short.

The bottom line?
If your inputs touch your output, you’re in feedstock territory. And if your records don’t match the scientific method, your eligibility is on shaky ground.

Let’s make sure you’re not the next test case.
Talk to us.

Scroll to Top